Traffic
324.41K
-18.98%MoMEstimated monthly visits
443.09K295.39K147.7K0
Global rank
156,638
Country rank · China
6,008
Category rank · Biotechnology and Pharmaceuticals
91
Average visit duration
00:36
Pages per visit
1.93
Bounce rate
43.58%
Domain age
13 years
Search share
50.3%
Traffic sources
- Search50.3%
- Direct36.5%
- Referrals11.4%
- Generative AI1.2%
- Social0.5%
- Display ads0.1%
- Other0.0%
- Paid search0.0%
Regions
- China59.2%
- Singapore10.6%
- United States8.2%
- Hong Kong SAR China7.6%
- Japan5.2%
See how pharmcube.com compares with the most visited websites in the world, the fastest growing websites and sites gaining organic search traffic.
Search visibility
Keyword samples
Estimated visitsMonthly searchesVisits ÷ searches
- 黄果2.28K76.65K3%
- 亦诺微mvr-t3011790—
- 医药魔方BRAND65084077%
- cd8 三抗 tcr580310187%
- tcelltech560—
Keyword rankings
Keyword rankings
86.4M
Search estimate
New 1 · Up 2
- Ranking keywords
- 12,400
- Landing pages
- 4
- Search competitors
- 4
- AI citations
- 2
PositionEstimated visits
- google#142M
- gmail#118.2M
- google maps#19.4M
- google drive#14.1M
Full keyword rankings are a Pro feature
Unlock ProSite profile
- HTTP 200
- Email authentication
- Hosting ASN
- HTTP
- 200
- Page size
- 56.8 KiB
- Hosting
- ALIBABA-CN-NET · AS37963
- Email authentication
- SPF · DMARC quarantine
- TLS
- TLSv1.3 · 178 days
Page and SEOSchema 6
- Final URL
- https://pharmcube.com/
- Title
- 医药魔方-致力于数据赋能医药创新,助力高效决策与数智化转型
- Description
- 医药魔方致力于赋能医药行业高效决策，通过将“数据+AI”与医药行业专家洞察的深度融合，打造具有行业前瞻性的创新数据产品及定制化解决方案，助力企业高效决策与数智化转型。 魔方已建立围绕药械全生命周期决策场景的服务能力，与近千家头部医药企业与投资机构建立长期稳定合作。拥有覆盖药品全生命周期的产品矩阵，包括：NextPharma 全球新药数据库、InvestGO 中国医疗健康投融资数据库、TrialCube全球临床试验数据库、PharmaBI市场销售数据库等
- Cross-origin redirect
- No
- Word count
- 1,269
- Internal / external links
- 23 / 13
- Canonical
- https://www.pharmcube.com/
- Language
- zh-CN
- H1 / H2
- 2 / 2
- Images missing alt
- 3 / 3
- Schema
- Brand · Offer · Organization · Product · SoftwareApplication · WebSite
- Hreflang
- zh-CN · en · x-default
- OG / Twitter
- OG · Twitter
Technology and tracking2 technologies
- Technology clues
- Nuxt · React
- External script hosts
- hm.baidu.com · o.alicdn.com · vcdn.pharmcube.com
- Social links
- linkedin.com · twitter.com · facebook.com · youtube.com
- Server
- nginx
- Security headers
- 1 / 6
- HSTS / CSP
- CSP
Email and DNS securitySet
- SPF
- Set
- DMARC
- Set · quarantine
- DKIM selectors
- Not found
- Mail stack
- Microsoft 365
- IPv6
- No AAAA
- Site verification TXT
- Microsoft
- SOA
- vip3.alidns.com
- NS
- vip4.alidns.com. · vip3.alidns.com.
- MX
- 1 mx1.feishu.cn. · 10 mx3.feishu.cn. · 5 mx2.feishu.cn. · 1 more
Hosting and networkAS37963
- A
- 47.94.42.207
- Hosting ASN
- AS37963 · 47.94.0.0/15
- Hosting organization
- ALIBABA-CN-NET - Hangzhou Alibaba Advertising Co.,Ltd.
- Hosting country
- CN
- BGP announcement
- Yes
- TLS
- TLSv1.3 · Verified
- Certificate issuer
- GeoTrust G2 TLS CN RSA4096 SHA256 2022 CA1
- Certificate remaining
- 178 days
- Certificate SAN
- DNS:*.pharmcube.com · DNS:pharmcube.com
robots and AI crawlingHTTP 200
- Robots.txt
- 200
- Global Disallow /
- No
- Sitemap
- Index · 1
- AI explicitly disallowed
- 0
- AI explicitly allowed
- 0
Well-known public paths
- Present / checked
- 0 / 5
Website information
- Domain
- pharmcube.com
- Registration status
- Domain registered
- Registered
- 2013-12-16
- Registrar
- Alibaba Cloud Computing (Beijing) Co., Ltd.
- Expires
- 2027-12-16
- Domain age
- 13 years
- DNSSEC
- No
- Registry status
- active
Similar sites
Website reports in the same category, with nearby monthly visits.
- ouryao.com
- alf-web.com
- allmed.pro
- astrazeneca.cn
- ilacfiyati.com
- tezspire.com
- drugshortage.jp
- tanabe-pharma.com
What's in this report
The report starts with a whole-site monthly visit estimate. Search visibility and public site facts follow when they exist.
- Website traffic is a modeled whole-site estimate, with a source, observation period and confidence.
- Search visibility is ranking keywords and search traffic, listed separately from whole-site visits.
- Missing or partial values stay marked in the report.